Price $0.35 |
Market Cap
7.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
18.17
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-3.9K
|
FCF
-0.1
|
|
Op. Margin
-860.70%
|
Net Margin
-937.10%
|
ROE
135.60%
|
ROI
-603.20%
|
|
ROA
-149.30%
|
EPS Growth
49.30%
|
Current Ratio
0.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Therapeutics Inc (ASRT) | $1.17 | - | - | 92.7M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $1.43 | - | - | 5.5M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.68 | - | - | 13.8M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $22.54 | - | - | 7.65B | Strong Buy |
| United Therapeutics Corporatio (UTHR) | $82.14 | - | - | 3.6B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
